6.02
price down icon0.50%   -0.03
after-market After Hours: 6.10 0.08 +1.33%
loading
Kura Oncology Inc stock is traded at $6.02, with a volume of 1.19M. It is down -0.50% in the last 24 hours and up +7.50% over the past month. Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
See More
Previous Close:
$6.05
Open:
$6
24h Volume:
1.19M
Relative Volume:
0.95
Market Cap:
$521.18M
Revenue:
-
Net Income/Loss:
$-168.09M
P/E Ratio:
-2.7742
EPS:
-2.17
Net Cash Flow:
$-138.01M
1W Performance:
-3.37%
1M Performance:
+7.50%
6M Performance:
-23.89%
1Y Performance:
-70.18%
1-Day Range:
Value
$5.865
$6.09
1-Week Range:
Value
$5.865
$6.59
52-Week Range:
Value
$5.41
$21.57

Kura Oncology Inc Stock (KURA) Company Profile

Name
Name
Kura Oncology Inc
Name
Phone
(858) 500-8800
Name
Address
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Name
Employee
192
Name
Twitter
@kuraoncology
Name
Next Earnings Date
2025-02-21
Name
Latest SEC Filings
Name
KURA's Discussions on Twitter

Compare KURA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
KURA
Kura Oncology Inc
6.02 523.78M 0 -168.09M -138.01M -2.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Kura Oncology Inc Stock (KURA) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-06-25 Downgrade BTIG Research Buy → Neutral
Oct-24-24 Initiated UBS Buy
Oct-14-24 Downgrade Stifel Buy → Hold
Dec-22-23 Initiated Mizuho Buy
Aug-11-23 Initiated BofA Securities Buy
Jul-27-23 Initiated Scotiabank Sector Perform
May-17-23 Initiated BTIG Research Buy
Jan-31-23 Initiated Stifel Buy
Jul-12-22 Initiated Cantor Fitzgerald Overweight
Feb-15-22 Initiated Jefferies Buy
May-05-21 Resumed Credit Suisse Outperform
Apr-26-21 Resumed Credit Suisse Outperform
Dec-07-20 Reiterated H.C. Wainwright Buy
Dec-03-20 Initiated Stifel Buy
Nov-05-20 Downgrade Piper Sandler Overweight → Neutral
Jul-07-20 Initiated Credit Suisse Outperform
May-05-20 Initiated Barclays Overweight
Jul-18-19 Initiated Deutsche Bank Buy
Nov-09-18 Initiated Piper Jaffray Overweight
Aug-01-18 Initiated H.C. Wainwright Buy
Oct-13-16 Resumed Leerink Partners Outperform
Jan-22-16 Initiated JMP Securities Mkt Outperform
Dec-30-15 Initiated Oppenheimer Outperform
Dec-16-15 Initiated Citigroup Buy
View All

Kura Oncology Inc Stock (KURA) Latest News

pulisher
12:59 PM

How strong is Kura Oncology Inc. company’s balance sheetLow Risk Growth Plan With Low Risk - jammulinksnews.com

12:59 PM
pulisher
10:59 AM

Why Kura Oncology Inc. stock attracts strong analyst attentionFree Expert-Led Investment Training - beatles.ru

10:59 AM
pulisher
07:55 AM

How does Kura Oncology Inc. generate profit in a changing economyEntry Signal Report For Beginners - jammulinksnews.com

07:55 AM
pulisher
Jul 31, 2025

What makes Kura Oncology Inc. stock price move sharplyWealth Building Insights With Low Risk - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What institutional investors are buying Kura Oncology Inc. stockFree Stock Trend Scanner That Work - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Kura Oncology Sets Q2 Earnings Date: Cancer Drug Pipeline Update Coming August 7 - Stock Titan

Jul 31, 2025
pulisher
Jul 31, 2025

Kura Oncology to Report Second Quarter 2025 Financial Results - The Manila Times

Jul 31, 2025
pulisher
Jul 30, 2025

Using flow based indicators on Kura Oncology Inc.Real-Time AI Generated Market Forecast - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Investor Network: Kura Oncology, Inc. to Host Earnings Call - ACCESS Newswire

Jul 29, 2025
pulisher
Jul 29, 2025

Kura Oncology Inc. Recovery Potential Based on Technical ToolsWeekly Return Pick Forecast Reports Show Trend - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

How to use a screener to detect Kura Oncology Inc. breakoutsSwing Trade Signal and Price Prediction - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Kura Oncology Inc. in the next 12 monthsStock Strategy Recommendation For Every Investor - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Cwm LLC Purchases 25,497 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jul 28, 2025
pulisher
Jul 28, 2025

What are the latest earnings results for Kura Oncology Inc.Dynamic profit expansion - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What catalysts could drive Kura Oncology Inc. stock higher in 2025Record-setting profit potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Kura Oncology Inc. a Top Dividend Stock to Watch in 2025Minimized Risk Maximum Return - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

What is Kura Oncology Inc. company’s growth strategyRapid growth opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Kura Oncology Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree Discussion Group - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Kura Oncology Inc. Stock Analysis and ForecastSuperior investment outcomes - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will Kura Oncology Inc. stock benefit from interest rate changesPhenomenal capital gains - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Can Kura Oncology Inc. stock recover from recent declineGame-changing returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Kura Oncology Inc. stockOverwhelming financial success - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Is Kura Oncology Inc. a good long term investmentFree Real-Time Stock Data - Autocar Professional

Jul 24, 2025
pulisher
Jul 22, 2025

What drives Kura Oncology Inc. stock priceAccelerated wealth building - jammulinksnews.com

Jul 22, 2025

Kura Oncology Inc Stock (KURA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Kura Oncology Inc Stock (KURA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
FORD KATHLEEN
Chief Operating Officer
May 19 '25
Sale
6.28
1,558
9,777
21,367
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):